Acquired (autoimmune) TTP is developed due to the advent of IgG autoantibodies against ADAMTS13, leading to the destruction of this enzyme and its deficiency [7,8]. This evidence concerns the gene ADAMTS13 and thrombotic thrombocytopenic purpura.